IMU

Immunai

Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.

Omniscope

Omniscope develops an immune intelligence platform for individuals, clinicians and researchers to track immune system health, disease drivers and cellular aging over time.

Preview Health

This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.

Immunara

This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.

One Biosciences

One Biosciences develops an AI-powered single-cell transcriptomic platform to provide functional tumour profiling for oncologists and pharmaceutical companies.

Asylia Diagnostics

This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.

Teiko Bio

Teiko Bio develops immune profiling platforms using mass cytometry to provide drug target discovery and biomarker analysis for biopharmaceutical companies and clinical researchers.

Biome Diagnostics

This company develops AI-powered microbiome diagnostic tools and cancer immunotherapy prediction tests for healthcare professionals, laboratories, and individual consumers.